FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319005180> ?p ?o ?g. }

• W4319005180 endingPage "26" @default.
• W4319005180 startingPage "26" @default.
• W4319005180 abstract "Introduction: Non-small-cell lung cancer is still diagnosed at an inoperable stage and systematic treatment is the only option. Immunotherapy is currently considered to be the tip of the arrow as the first-line treatment for patients with a programmed death-ligand 1 ≥ 50. Sleep is known to be an essential part of our everyday life. Patients and Methods: We investigated, upon diagnosis and after nine months, 49 non-small-cell lung cancer patients undergoing immunotherapy treatment with nivolumab and pemprolisumab. A polysomnographic examination was conducted. Moreover, the patients completed the Epworth Sleepiness Scale (ESS), the Pittsburgh Sleep Quality Index (PSQI), the Fatigue Severity Scale (FSS) and the Medical Research Council (MRC) dyspnea scale. Results: Tukey mean-difference plots, summary statistics, and the results of paired t-test of five questionnaire responses in accordance with the PD-L1 test across groups were examined. The results indicated that, upon diagnosis, patients had sleep disturbances which were not associated with brain metastases or their PD-L1 expression status. However, the PD-L1 status and disease control were strongly associated, since a PD-L1 ≥80 improved the disease status within the first 4 months. All data from the sleep questionnaires and polysomnography reports indicated that the majority of patients with a partial response and complete response had their initial sleep disturbances improved. There was no connection between nivolumab or pembrolisumab and sleep disturbances. Conclusion: Upon diagnosis, lung cancer patients have sleep disorders such as anxiety, early morning wakening, late sleep onset, prolonged nocturnal waking periods, daytime sleepiness, and unrefreshing sleep. However, these symptoms tend to improve very quickly for patients with a PD-L1 expression ≥80, because disease status improves also very quickly within the first 4 months of treatment." @default.
• W4319005180 created "2023-02-03" @default.
• W4319005180 creator A5002201877 @default.
• W4319005180 creator A5010883286 @default.
• W4319005180 creator A5017367488 @default.
• W4319005180 creator A5017748928 @default.
• W4319005180 creator A5031354667 @default.
• W4319005180 creator A5037835689 @default.
• W4319005180 creator A5055863669 @default.
• W4319005180 creator A5056169745 @default.
• W4319005180 creator A5059141492 @default.
• W4319005180 creator A5077198005 @default.
• W4319005180 creator A5080024937 @default.
• W4319005180 date "2023-02-01" @default.
• W4319005180 modified "2023-09-25" @default.
• W4319005180 title "Non-Small-Cell Lung Cancer Immunotherapy and Sleep Characteristics: The Crossroad for Optimal Survival" @default.
• W4319005180 cites W104281766 @default.
• W4319005180 cites W134450455 @default.
• W4319005180 cites W1833969064 @default.
• W4319005180 cites W1972058028 @default.
• W4319005180 cites W1975943114 @default.
• W4319005180 cites W1986401088 @default.
• W4319005180 cites W2004448470 @default.
• W4319005180 cites W2023148731 @default.
• W4319005180 cites W2073843950 @default.
• W4319005180 cites W2112502628 @default.
• W4319005180 cites W2133536961 @default.
• W4319005180 cites W2150471053 @default.
• W4319005180 cites W2232088377 @default.
• W4319005180 cites W2247536620 @default.
• W4319005180 cites W2746024783 @default.
• W4319005180 cites W2765790964 @default.
• W4319005180 cites W2910331921 @default.
• W4319005180 cites W2997207867 @default.
• W4319005180 cites W3032076269 @default.
• W4319005180 cites W3138806634 @default.
• W4319005180 cites W4210885300 @default.
• W4319005180 cites W4220987315 @default.
• W4319005180 cites W4231781601 @default.
• W4319005180 cites W4289524407 @default.
• W4319005180 cites W4292560523 @default.
• W4319005180 cites W4293776831 @default.
• W4319005180 cites W4296099256 @default.
• W4319005180 cites W4296794429 @default.
• W4319005180 cites W4304956762 @default.
• W4319005180 cites W4306179674 @default.
• W4319005180 cites W4306377228 @default.
• W4319005180 cites W4308866983 @default.
• W4319005180 cites W4318972676 @default.
• W4319005180 cites W56317326 @default.
• W4319005180 doi "https://doi.org/10.3390/diseases11010026" @default.
• W4319005180 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36810540" @default.
• W4319005180 hasPublicationYear "2023" @default.
• W4319005180 type Work @default.
• W4319005180 citedByCount "0" @default.
• W4319005180 crossrefType "journal-article" @default.
• W4319005180 hasAuthorship W4319005180A5002201877 @default.
• W4319005180 hasAuthorship W4319005180A5010883286 @default.
• W4319005180 hasAuthorship W4319005180A5017367488 @default.
• W4319005180 hasAuthorship W4319005180A5017748928 @default.
• W4319005180 hasAuthorship W4319005180A5031354667 @default.
• W4319005180 hasAuthorship W4319005180A5037835689 @default.
• W4319005180 hasAuthorship W4319005180A5055863669 @default.
• W4319005180 hasAuthorship W4319005180A5056169745 @default.
• W4319005180 hasAuthorship W4319005180A5059141492 @default.
• W4319005180 hasAuthorship W4319005180A5077198005 @default.
• W4319005180 hasAuthorship W4319005180A5080024937 @default.
• W4319005180 hasBestOaLocation W43190051801 @default.
• W4319005180 hasConcept C118552586 @default.
• W4319005180 hasConcept C121608353 @default.
• W4319005180 hasConcept C126322002 @default.
• W4319005180 hasConcept C143998085 @default.
• W4319005180 hasConcept C1513209611 @default.
• W4319005180 hasConcept C2776245837 @default.
• W4319005180 hasConcept C2776256026 @default.
• W4319005180 hasConcept C2778205975 @default.
• W4319005180 hasConcept C2778664715 @default.
• W4319005180 hasConcept C2781210498 @default.
• W4319005180 hasConcept C2781326671 @default.
• W4319005180 hasConcept C2983189541 @default.
• W4319005180 hasConcept C71924100 @default.
• W4319005180 hasConceptScore W4319005180C118552586 @default.
• W4319005180 hasConceptScore W4319005180C121608353 @default.
• W4319005180 hasConceptScore W4319005180C126322002 @default.
• W4319005180 hasConceptScore W4319005180C143998085 @default.
• W4319005180 hasConceptScore W4319005180C1513209611 @default.
• W4319005180 hasConceptScore W4319005180C2776245837 @default.
• W4319005180 hasConceptScore W4319005180C2776256026 @default.
• W4319005180 hasConceptScore W4319005180C2778205975 @default.
• W4319005180 hasConceptScore W4319005180C2778664715 @default.
• W4319005180 hasConceptScore W4319005180C2781210498 @default.
• W4319005180 hasConceptScore W4319005180C2781326671 @default.
• W4319005180 hasConceptScore W4319005180C2983189541 @default.
• W4319005180 hasConceptScore W4319005180C71924100 @default.
• W4319005180 hasIssue "1" @default.
• W4319005180 hasLocation W43190051801 @default.
• W4319005180 hasLocation W43190051802 @default.
• W4319005180 hasLocation W43190051803 @default.

• next